Heart failure could be reversed with a new treatment that combines medication with the temporary use of an artificial heart pump, said researchers at the University of Utah Health.  The therapy, which involves implantation of a left ventricular assist device ( LVAD ), could: help reverse structural damage to the heart, eliminate the need for
0 Comments
A recent study demonstrated that Google search trends could help in predicting COVID-19 hot spots.   Web-based activity detection tools can play an important role in the early detection of infectious diseases. These internet search behaviour tools may also help in the timely preparedness of health care systems to avoid the adverse consequences of being
0 Comments
This content originally appeared on Low Carb Yum. Republished with permission. Regular gravy is usually thickened with wheat flour or cornstarch. We all know wheat flour isn’t low in carbs. But, is cornstarch keto? At about 7 grams of carbs per tablespoon, cornstarch can be a low carb option if a small amount is used.
0 Comments
Immunotherapy with pembrolizumab holds promise for improving the generally dismal outlook in patients with leptomeningeal metastases, a phase 2 trial suggests. Results from the trial were reported at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting. “Unfortunately, when patients present with leptomeningeal disease, they usually have a poor prognosis. Their median survival is
0 Comments
New report calls on senior higher education staff to undergo training ‘to improve racial literacy as part of a sector-wide crackdown’ Tackling racial harassment in higher education sheds light on the ongoing racial discrimination people face at university, stating unis are guilty of ‘perpetuating institutional racism’ on campus and calling on leaders in the higher
0 Comments
Researchers are investigating the potential of the broad spectrum anti-microbial ivermectin for COVID-19 treatment. As the COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to spread around the world, researchers are looking for candidate drugs to use as potential therapies. Repurposing drugs already in use for other infections could allow a quicker route to finding
0 Comments
Nov 24 2020 Allerød, Denmark –Pharmaceutical companies worldwide are diligently working overtime to produce an accepted COVID-19 vaccine. While this work continues, other companies are already planning how to distribute a potential vaccine.  Perhaps the most significant challenge exists in temperature control, as some COVID-19 vaccine candidates will require ultra-low temperature (ULT), typically ranging from
0 Comments
20 November 2020 –  AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the approved indications of unresectable Stage III non-small cell lung cancer (NSCLC) after chemoradiation therapy (CRT) and previously treated advanced bladder cancer. This new option is consistent with the
0 Comments
November 19, 2020 Audience: Consumer, Patient, Health Professional, Pharmacy November 19, 2020 — Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 24 2020 In the most comprehensive analysis to date of U.S. children tested and treated for COVID-19, an organization representing seven of the nation’s largest pediatric medical centers reports that some groups of children are faring significantly worse than children in general during the pandemic. Findings from the PEDSnet organization–which
0 Comments
Healthcare workers and residents of long-term care facilities may be first in line to get the COVID-19 vaccine, followed by essential workers and then adults with high-risk medical conditions and older adults, members of the CDC’s Advisory Committee on Immunization Practices (ACIP) agreed during a Monday meeting. These new groups would be phase 1a, phase
0 Comments
Coronavirus cases are spiking across the country, and local and state governments are trying to curb the spread.  Here’s a synopsis of pandemic-created changes to review as we head into winter and the holiday season. In most cities, expect indoor dining to no longer be an option — it’s already happened in Philadelphia and St.
0 Comments
A dance between shadow and light that we can all relate to – we explore the meaning behind komorebi, and the lessons it can teach us about mental health Every time I look up from my desk, I see my favourite art print – The Shyness of Trees by Marcel George. Imagining you’re looking straight
0 Comments
After many years of good management of their high blood pressure, Americans are letting that control slip: the number of Americans with uncontrolled blood pressure rates has been rising. And while this trend has been creeping up since 2015, Covid-19, as with most things today, seems to have left its mark.   These increasing numbers aren’t
0 Comments
A new research study detects pre-existing antibody-driven immunity against SARS-CoV-2 in some individuals, with higher rates in uninfected children. Different age groups appear to have different responses to COVID-19, with kids often presenting with mild or no symptoms. However, the reason for this remains relatively unclear.  Although COVID-19 is at the forefront of the news
0 Comments
KENILWORTH, N.J.–(BUSINESS WIRE) November 16, 2020 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a collaboration with the Bill & Melinda Gates Foundation (the foundation) where the foundation is committing to provide funding to support a pivotal Phase 3 study investigating a once-monthly oral pre-exposure prophylaxis (PrEP)1
0 Comments
FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Zokinvy (lonafarnib) for the
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 20 2020 Today, the U.S. Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients one year of age and older. Zokinvy is not approved for use in patients with
0 Comments